Artelo Biosciences, Inc. functions as a clinical-stage biopharmaceutical enterprise dedicated to discovering and advancing therapies that modulate the endocannabinoid system.
52W Range
0thpctl
Volume
0.11×avg
Market Cap
1.36MUSD
P/E Ratio
-0.0TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
Artelo Biosciences, Inc.
ARTLNASDAQ Capital Market·USD·Closed
Artelo Biosciences, Inc.
ARTLNASDAQ·USD·Closed
$3.51
−4.62%
$3.51
−$0.17 (4.62%)
52W Range
0thpctl
Volume
0.11×avg
Mkt Cap
1.36MUSD
P/E
-0.0TTM
Div Yield
–ann
ARTL: Artelo Biosciences, Inc. Stock Analysis | finqOS
